Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro

Triple-negative breast cancer (TNBC) is one of the most aggressive types of cancer, and treatment is limited to chemotherapy and radiation. Oncolytic virotherapy may be a promising approach to treat TNBC. However, oncolytic adenovirus (OAd)-based mono-therapeutic clinical trials have resulted in mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Garza-Morales, Rodolfo, Gonzalez-Ramos, Roxana, Chiba, Akiko, Montes de Oca-Luna, Roberto, McNally, Lacey R., McMasters, Kelly M., Gomez-Gutierrez, Jorge G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977117/
https://www.ncbi.nlm.nih.gov/pubmed/29772755
http://dx.doi.org/10.3390/cancers10050144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977117/
https://www.ncbi.nlm.nih.gov/pubmed/29772755
http://dx.doi.org/10.3390/cancers10050144

Ejemplares similares